Evidence map›Paper›PMID 32589699›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Epidemiology of Invasive Haemophilus influenzae Serotype a Disease-United States, 2008-2017.

Heidi M Soeters, Sara E Oliver, Ian D Plumb, Amy E Blain, Tammy Zulz, Brenna C Simons, Meghan Barnes, Monica M Farley, Lee H Harrison, Ruth Lynfield and 14 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Carriage ofJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  6. Article
  7. Article
  8. Report ofPediatric investigation · 2023
    Article
  9. Article
  10. Article
  11. Frontiers in microbiology · 2023
    Article
  12. Article
  13. Review
  14. Epidemiology of invasiveInternational journal of circumpolar health · 2022
    Article
  15. Article
  16. Article
  17. Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 1 country.

Heidi M SoetersCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.ORCID 0000-0002-9415-9340
Sara E OliverCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Ian D PlumbCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Amy E BlainCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Tammy ZulzArctic Investigations Program, CDC, Anchorage, Alaska, USA.
Brenna C SimonsArctic Investigations Program, CDC, Anchorage, Alaska, USA.
Meghan BarnesColorado Department of Public Health and Environment, Denver, Colorado, USA.
Monica M FarleyEmory University School of Medicine and The Atlanta VA Medical Center, Atlanta, Georgia, USA.
Lee H HarrisonJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ruth LynfieldMinnesota Department of Health, St Paul, Minnesota, USA.
Stephanie MassayAlaska Division of Public Health, Anchorage, Alaska, USA.
Joseph McLaughlinAlaska Division of Public Health, Anchorage, Alaska, USA.
Alison G MuseNew York State Department of Health, Albany, New York, USA.
Susan PetitConnecticut Department of Public Health, Hartford, Connecticut, USA.
William SchaffnerVanderbilt University School of Medicine, Nashville, Tennessee, USA.
Ann ThomasOregon Health Authority, Portland, Oregon, USA.
Salina TorresNew Mexico Department of Health, Santa Fe, New Mexico, USA.
James WattCalifornia Department of Public Health, Richmond, California, USA.
Tracy PondoCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Melissa J WhaleyCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Fang HuCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Xin WangCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Elizabeth C BriereCenters for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Michael G BruceArctic Investigations Program, CDC, Anchorage, Alaska, USA.
Centers for Disease Control and Prevention · USAlaska Department of Health and Social Services · USCalifornia Department of Public Health · USColorado Department of Public Health and Environment · USConnecticut Department of Public Health · USEmory University · USJohns Hopkins University · USMinnesota Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USOregon Health Authority · USVanderbilt University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundHaemophilus influenzae serotype a (Hia) can cause invasive disease similar to serotype b; no Hia vaccine is available. We describe the epidemiology of invasive Hia disease in the United States overall and specifically in Alaska during 2008-2017.

methodsActive population- and laboratory-based surveillance for invasive Hia disease was conducted through Active Bacterial Core surveillance sites and from Alaska statewide invasive bacterial disease surveillance. Sterile-site isolates were serotyped via slide agglutination or real-time polymerase chain reaction. Incidences in cases per 100 000 were calculated.

resultsFrom 2008 to 2017, an estimated average of 306 invasive Hia disease cases occurred annually in the United States (estimated annual incidence: 0.10); incidence increased by an average of 11.1% annually. Overall, 42.7% of cases were in children aged <5 years (incidence: 0.64), with highest incidence among children aged <1 year (1.60). Case fatality was 7.8% overall and was highest among adults aged ≥65 years (15.1%). Among children aged <5 years, the incidence was 17 times higher among American Indian and Alaska Native (AI/AN) children (8.29) than among children of all other races combined (0.49). In Alaska, incidences among all ages (0.68) and among children aged <1 year (24.73) were nearly 6 and 14 times higher, respectively, than corresponding US incidences. Case fatality in Alaska was 10.2%, and the vast majority (93.9%) of cases occurred among AI/AN.

conclusionsIncidence of invasive Hia disease has increased since 2008, with the highest burden among AI/AN children. These data can inform prevention strategies, including Hia vaccine development.

Indexed as

Haemophilus InfectionsAdultAlaskaChildHaemophilus influenzaeHumansIncidenceSerogroupSerotypingUnited StatesVaccines, ConjugateVaccines, ConjugateAmerican Indian and Alaska NativeepidemiologyHaemophilus influenzaeinvasive diseaseserotype asurveillance

Identifiers

PMID32589699
PMCPMC9628811
OpenAlexW3037894379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.